Synthesis and analgesic effects of 3-substituted 4,6-diarylpyridazine derivatives of the arylpiperazine class

被引:44
作者
Rohet, F [1 ]
Rubat, C [1 ]
Coudert, P [1 ]
Couquelet, J [1 ]
机构
[1] UNIV AUVERGNE,FAC PHARM,PHARMACOL LAB,F-63001 CLERMONT FERRAN,FRANCE
关键词
D O I
10.1016/S0968-0896(97)00006-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A new series of 4,6-diaryl pyridazines substituted in the 3-position by arylpiperazinyl moieties was synthesized and evaluated for analgesic activity. Five out of the nine tested compounds possessed significant antinociceptive effects in the phenylbenzoquinone-induced writhing test (PBQ test) with ED50 values ranging from 26.0 to 37.7 mg/kg ip. The most active derivatives 2a, 2d and 2h had a low toxicity (LD50 > 800 mg/kg ip) but showed some sedative and neurotoxic effects from the dose of 50 mg/kg ip. The three selected pyridazines were devoid of activity in the hot-plate test. However, analgesic activity of 2d and 2h was significantly reversed by naloxone in the PBQ test. Administered at the low dose of 5 mg/kg ip, 2h greatly potentiated the antinociceptive response induced by morphine (0.15 mg/kg sc). In addition, analgesic effects of 2h (2.5 mg/kg ip) were also potentiated by 5-hydroxytryptophan combined with carbidopa. These results suggest that pyridazine 2h induces analgesia, which is mediated via both opioid and serotonergic mechanisms. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:655 / 659
页数:5
相关论文
共 24 条
[1]  
BOISSIER JR, 1965, ARCH INT PHARMACOD T, V158, P212
[2]   A NEW SYNTHETIC ROUTE TO 4,6-DIARYLPYRIDAZINONES AND SOME OF THEIR DERIVATIVES [J].
COUDERT, P ;
COUQUELET, J ;
TRONCHE, P .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1988, 25 (03) :799-802
[3]  
ERDOGAN H, 1991, ARZNEIMITTEL-FORSCH, V41-1, P73
[4]  
FIALIP J, 1989, J PHARMACOL EXP THER, V248, P747
[5]   NOVEL NONOPIOID NON-ANTIINFLAMMATORY ANALGESICS - 3-(AMINOALKYL) AND 3-[(4-ARYL-1-PIPERAZINYL)ALKYL]OXAZOLO[4,5-B]PYRIDIN-2(3H)-ONES [J].
FLOUZAT, C ;
BRESSON, Y ;
MATTIO, A ;
BONNET, J ;
GUILLAUMET, G .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (04) :497-503
[6]  
KINNARD WJ, 1957, J PHARMACOL EXP THER, V121, P354
[7]  
LINEE P, 1972, Journal de Pharmacologie (Paris), V3, P513
[8]  
LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
[9]  
MOREAU S, 1996, J ARZNEIM FORSCH, V46, P800
[10]  
NEVINSON MJ, 1991, BRIT J PHARM P S, V104, P267